XML 121 R107.htm IDEA: XBRL DOCUMENT v3.8.0.1
SELECTED CONSOLIDATING FINANCIAL STATEMENTS OF PARENT, GUARANTORS AND NON-GUARANTORS (Details 3) - USD ($)
$ in Thousands
12 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Mar. 31, 2016
Consolidating Financial Statements, Captions      
Net income (loss) $ (425,391) $ (42,952) $ (1,047,960)
Adjustments to reconcile net income to net cash (used in) provided by operating activities 136,497 324,474 1,131,823
Net cash provided by operating activities (288,894) 281,522 83,863
Capital expenditures (42,050) (51,832) (80,047)
Reimbursement Revenue     0
Proceeds from sale of assets 83,082 86,187 6,069
Acquisitions, net of cash acquired (2,818) 9 (54,051)
Net cash used in investing activities 38,214 34,364 (128,029)
Net increase (decrease) in revolving credit facility 82,888 (110,000) (8,256)
Proceeds on issuance of debt 544,243 24,400 134,797
Retirements and repayments of debt (387,373) (144,144) (80,917)
Payment of deferred financing costs (17,729) (14,034) (185)
Dividends paid (7,943) (7,927) (7,889)
Receipt (Repayment) of Government Grants   (14,570) (5,000)
Repurchase of restricted shares for minimum tax obligation (483) (182) (96)
Intercompany financing and advances 0 0 0
Net cash (used in) provided by financing activities 213,603 (266,457) 32,454
Effect of exchange rate changes on cash and cash equivalents 3,263 (780) 79
Net change in cash and cash equivalents (33,814) 48,649 (11,633)
Cash at beginning of period 69,633 20,984 32,617
Cash at end of period 35,819 69,633 20,984
Parent      
Consolidating Financial Statements, Captions      
Net income (loss) (38,396) (25,700) 74,173
Adjustments to reconcile net income to net cash (used in) provided by operating activities (25,181) 36,295 (106,837)
Net cash provided by operating activities (63,577) 10,595 (32,664)
Capital expenditures (4,179) (2,281) (986)
Reimbursement Revenue     0
Proceeds from sale of assets 0 45,288 0
Acquisitions, net of cash acquired 0 0 0
Net cash used in investing activities (4,179) 43,007 (986)
Net increase (decrease) in revolving credit facility 82,888 (110,000) (8,256)
Proceeds on issuance of debt 500,000 0 0
Retirements and repayments of debt (314,999) (28,473) (19,024)
Payment of deferred financing costs (17,729) (14,034) (185)
Dividends paid (7,943) (7,927) (7,889)
Receipt (Repayment) of Government Grants   0 0
Repurchase of restricted shares for minimum tax obligation (483) (182) (96)
Intercompany financing and advances (193,876) 125,412 70,024
Net cash (used in) provided by financing activities 47,858 (35,204) 34,574
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents (19,898) 18,398 924
Cash at beginning of period 19,942 1,544 620
Cash at end of period 44 19,942 1,544
Guarantors Subsidiaries      
Consolidating Financial Statements, Captions      
Net income (loss) (313,348) (37,037) (1,104,311)
Adjustments to reconcile net income to net cash (used in) provided by operating activities 93,849 260,469 1,207,850
Net cash provided by operating activities (219,499) 223,432 103,539
Capital expenditures (32,445) (37,436) (57,503)
Reimbursement Revenue     0
Proceeds from sale of assets 82,445 23,316 5,877
Acquisitions, net of cash acquired 0 9 (48,051)
Net cash used in investing activities 50,000 (14,111) (99,677)
Net increase (decrease) in revolving credit facility 0 0 0
Proceeds on issuance of debt 743 0 6,497
Retirements and repayments of debt (23,774) (12,871) (24,893)
Payment of deferred financing costs 0 0 0
Dividends paid 0 0 0
Receipt (Repayment) of Government Grants   (14,570) (5,000)
Repurchase of restricted shares for minimum tax obligation 0 0 0
Intercompany financing and advances 168,393 (157,944) 19,316
Net cash (used in) provided by financing activities 145,362 (185,385) (4,080)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents (24,137) 23,936 (218)
Cash at beginning of period 24,137 201 419
Cash at end of period 0 24,137 201
Non-Guarantor Subsidiaries      
Consolidating Financial Statements, Captions      
Net income (loss) (73,647) 19,785 (17,822)
Adjustments to reconcile net income to net cash (used in) provided by operating activities 65,048 12,443 24,629
Net cash provided by operating activities (8,599) 32,228 6,807
Capital expenditures (5,426) (12,115) (21,558)
Reimbursement Revenue     0
Proceeds from sale of assets 637 17,583 192
Acquisitions, net of cash acquired (2,818) 0 (6,000)
Net cash used in investing activities (7,607) 5,468 (27,366)
Net increase (decrease) in revolving credit facility 0 0 0
Proceeds on issuance of debt 43,500 24,400 128,300
Retirements and repayments of debt (48,600) (102,800) (37,000)
Payment of deferred financing costs 0 0 0
Dividends paid 0 0 0
Receipt (Repayment) of Government Grants   0 0
Repurchase of restricted shares for minimum tax obligation 0 0 0
Intercompany financing and advances 28,264 47,799 (83,159)
Net cash (used in) provided by financing activities 23,164 (30,601) 8,141
Effect of exchange rate changes on cash and cash equivalents 3,263 (780) 79
Net change in cash and cash equivalents 10,221 6,315 (12,339)
Cash at beginning of period 25,554 19,239 31,578
Cash at end of period 35,775 25,554 19,239
Consolidation, Eliminations [Member]      
Consolidating Financial Statements, Captions      
Net income (loss) 0 0 0
Adjustments to reconcile net income to net cash (used in) provided by operating activities 2,781 15,267 6,181
Net cash provided by operating activities 2,781 15,267 6,181
Capital expenditures 0 0 0
Reimbursement Revenue     0
Proceeds from sale of assets 0 0 0
Acquisitions, net of cash acquired 0 0 0
Net cash used in investing activities 0 0 0
Net increase (decrease) in revolving credit facility 0 0 0
Proceeds on issuance of debt 0 0 0
Retirements and repayments of debt 0 0 0
Payment of deferred financing costs 0 0 0
Dividends paid 0 0 0
Receipt (Repayment) of Government Grants   0 0
Repurchase of restricted shares for minimum tax obligation 0 0 0
Intercompany financing and advances (2,781) (15,267) (6,181)
Net cash (used in) provided by financing activities (2,781) (15,267) (6,181)
Effect of exchange rate changes on cash and cash equivalents 0 0 0
Net change in cash and cash equivalents 0 0 0
Cash at beginning of period 0 0 0
Cash at end of period $ 0 $ 0 $ 0